How many institutions held ABUS - Arbutus Biopharma Corp - Common Shares, without par value in Q1 2017?

50 institutional investors reported ABUS - Arbutus Biopharma Corp - Common Shares, without par value for Q1 2017. Use the holders table for investor-level position and value details.

Arbutus Biopharma Corp - Common Shares, without par value (ABUS)

Q: What does CUSIP 03879J100 represent in this 13F holders report?

CUSIP 03879J100 is the security identifier for ABUS - Arbutus Biopharma Corp - Common Shares, without par value used to aggregate holder disclosures.

CUSIP: 03879J100

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class: Equity / Common Shares, without par value
Shares outstanding: 194,990,877
Total 13F shares: 36,322,621
Share change: +113,993
Total reported value: $118,047,315
Put/Call ratio: 2400%
Price per share: $3.25
Number of holders: 50
Value change: +$819,274
Number of buys: 19
Number of sells: 31

Quarterly Holders Quick Answers

What is CUSIP 03879J100?
CUSIP 03879J100 identifies ABUS - Arbutus Biopharma Corp - Common Shares, without par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2017
Previous quarter: Q4 2016

Recent filing periods for CUSIP 03879J100:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ABUS - Arbutus Biopharma Corp - Common Shares, without par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
QVT Financial LP	13F	Company	8.2%	16,013,540	$39,233,000	—	31 Dec 2016	13F
LADENBURG THALMANN FINANCIAL SERVICES INC.	13F	Company	2.7%	5,294,945	$12,972,000	—	31 Dec 2016	13F
PRIMECAP MANAGEMENT CO/CA/	13F	Company	2%	3,935,000	$9,641,000	—	31 Dec 2016	13F
ARMISTICE CAPITAL, LLC	13F	Company	0.99%	1,940,000	$4,753,000	—	31 Dec 2016	13F
D. E. Shaw & Co., Inc.	13F	Company	0.89%	1,734,603	$4,250,000	—	31 Dec 2016	13F
Alpha Wave Global, LP	13F	Company	0.85%	1,655,162	$4,055,000	—	31 Dec 2016	13F
BANK OF MONTREAL /CAN/	13F	Company	0.45%	885,197	$2,346,000	—	31 Dec 2016	13F
AXA S.A.	13F	Company	0.41%	808,018	$1,980,000	—	31 Dec 2016	13F
SABBY MANAGEMENT, LLC	13F	Company	0.41%	792,617	$1,942,000	—	31 Dec 2016	13F
K2 PRINCIPAL FUND, L.P.	13F	Company	0.23%	443,887	$1,088,000	—	31 Dec 2016	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.19%	364,146	$892,000	—	31 Dec 2016	13F
MORGAN STANLEY	13F	Company	0.14%	278,000	$681,000	—	31 Dec 2016	13F
DAFNA Capital Management LLC	13F	Company	0.12%	234,000	$573,000	—	31 Dec 2016	13F
BAKER BROS. ADVISORS LP	13F	Company	0.09%	180,582	$442,000	—	31 Dec 2016	13F
CREDIT SUISSE AG/	13F	Company	0.09%	176,000	$431,000	—	31 Dec 2016	13F
OXFORD ASSET MANAGEMENT LLP	13F	Company	0.08%	160,186	$392,000	—	31 Dec 2016	13F
Telemetry Investments, L.L.C.	13F	Company	0.08%	150,000	$368,000	—	31 Dec 2016	13F
JENNISON ASSOCIATES LLC	13F	Company	0.07%	140,019	$343,000	—	31 Dec 2016	13F
Anson Funds Management LP	13F	Company	0.05%	105,085	$257,000	—	31 Dec 2016	13F
DEUTSCHE BANK AG\	13F	Company	0.05%	89,679	$219,000	—	31 Dec 2016	13F
VANGUARD GROUP INC	13F	Company	0.04%	74,490	$183,000	—	31 Dec 2016	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.04%	70,339	$172,000	—	31 Dec 2016	13F
CITIGROUP INC	13F	Company	0.03%	65,160	$160,000	—	31 Dec 2016	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.03%	56,328	$138,000	—	31 Dec 2016	13F
SIMPLEX TRADING, LLC	13F	Company	0.03%	54,527	$133,000	—	31 Dec 2016	13F
GROUP ONE TRADING LLC	13F	Company	0.02%	44,877	$110,000	—	31 Dec 2016	13F
Dynamic Technology Lab Private Ltd	13F	Company	0.02%	40,017	$98,000	—	31 Dec 2016	13F
MACKENZIE FINANCIAL CORP	13F	Company	0.02%	39,900	$98,000	—	31 Dec 2016	13F
CITADEL ADVISORS LLC	13F	Company	0.02%	38,148	$93,000	—	31 Dec 2016	13F
SCOTIA CAPITAL INC.	13F	Company	0.02%	35,500	$87,000	—	31 Dec 2016	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.01%	26,635	$65,000	—	31 Dec 2016	13F
WEDBUSH SECURITIES INC	13F	Company	0.01%	25,345	$62,000	—	31 Dec 2016	13F
DIALECTIC CAPITAL MANAGEMENT, LP	13F	Company	0.01%	25,000	$61,000	—	31 Dec 2016	13F
Virtu KCG Holdings LLC	13F	Company	0.01%	23,700	$58,000	—	31 Dec 2016	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.01%	22,000	$54,000	—	31 Dec 2016	13F
ROYAL BANK OF CANADA	13F	Company	0.01%	21,230	$52,000	—	31 Dec 2016	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.01%	19,204	$47,000	—	31 Dec 2016	13F
FMR LLC	13F	Company	0.01%	19,200	$47,000	—	31 Dec 2016	13F
TFS CAPITAL LLC	13F	Company	0.01%	14,195	$35,000	—	31 Dec 2016	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.01%	14,074	$34,000	—	31 Dec 2016	13F
Squarepoint Ops LLC	13F	Company	0.01%	13,400	$33,000	—	31 Dec 2016	13F
STATE STREET CORP	13F	Company	0.01%	12,300	$30,000	—	31 Dec 2016	13F
Cutler Group LLC / CA	13F	Company	0.01%	11,464	$28,000	—	31 Dec 2016	13F
Jefferies Group LLC	13F	Company	0.01%	10,300	$25,000	—	31 Dec 2016	13F
JPMORGAN CHASE & CO	13F	Company	0%	9,700	$24,000	—	31 Dec 2016	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	8,652	$21,000	—	31 Dec 2016	13F
Walleye Trading LLC	13F	Company	0%	7,000	$17,000	—	31 Dec 2016	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	3,195	$8,000	—	31 Dec 2016	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	2,450	$6,000	—	31 Dec 2016	13F
Creative Planning	13F	Company	0%	1,500	$4,000	—	31 Dec 2016	13F

Institutional Holders of Arbutus Biopharma Corp - Common Shares, without par value (ABUS) as of Q1 2017

As of 31 Mar 2017, Arbutus Biopharma Corp - Common Shares, without par value (ABUS) was held by 50 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 36,322,621 shares. The largest 10 holders included QVT Financial LP, LADENBURG THALMANN FINANCIAL SERVICES INC., PRIMECAP MANAGEMENT CO/CA/, D. E. Shaw & Co., Inc., ARMISTICE CAPITAL, LLC, RTW INVESTMENTS, LP, Falcon Edge Capital LP, BANK OF MONTREAL /CAN/, AXA, and SABBY MANAGEMENT, LLC. This page lists 50 institutional shareholders reporting positions in this security for the Q1 2017 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2017 vs Q4 2016 Across Filers

Q4 2016 holders

Q1 2017 holders

Holder diff

-2

Investor	Q4 2016 Shares	Q1 2017 Shares	Share Diff	Share Chg %	Q4 2016 Value $	Q1 2017 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.